Enfusion, Inc. (ENFN)
After hours:
| Previous Close | 9.51 |
| Open | 9.58 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1100 |
| Day's Range | 9.48 - 9.59 |
| 52 Week Range | 7.37 - 11.56 |
| Volume | |
| Avg. Volume | 422,770 |
| Market Cap | 865.149M |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | 136.00 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Enfusion Announces Date of First Quarter 2024 Results
NEW YORK & LONDON & HONG KONG, April 18, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its first quarter 2024 financial results before the U.S. financial markets open on Thursday, May 9, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results.
- Business Wire
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
NEW YORK, March 21, 2024--Enfusion, a best-in-class software-as-a-service (SaaS) platform for investment managers, today announced the completion of the second phase of a strategic investment management platform migration by Kayne Anderson. Kayne Anderson is a leading alternative investment management firm focused on real estate, infrastructure, energy, credit, and growth capital.
- Business Wire
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
NEW YORK & LONDON & HONG KONG, March 12, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading software-as-a-service (SaaS) platform for investment managers, has posted its fourth quarter and full year 2023 financial results as part of its 4Q 2023 Shareholder Letter which can be viewed here or by navigating to the Financials section of its Investor Relations website which can be found at http://ir.enfusion.com.
